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Background: Researchers and policy makers have determined that accounting for productivity costs, or “indirect
costs,” may be as important as including direct medical expenditures when evaluating the societal value of health
interventions. These costs are also important when estimating the global burden of disease. The estimation of
indirect costs is commonly done on a country-specific basis. However, there are few studies that evaluate indirect
costs across countries using a consistent methodology.
Methods: Using the human capital approach, we developed a model that estimates productivity costs as the
present value of lifetime earnings (PVLE) lost due to premature mortality. Applying this methodology, the model
estimates productivity costs for 29 selected countries, both developed and emerging. We also provide an
illustration of how the inclusion of productivity costs contributes to an analysis of the societal burden of smoking. A
sensitivity analysis is undertaken to assess productivity costs on the basis of the friction cost approach.
Results: PVLE estimates were higher for certain subpopulations, such as men, younger people, and people in
developed countries. In the case study, productivity cost estimates from our model showed that productivity loss
was a substantial share of the total cost burden of premature mortality due to smoking, accounting for over 75 %
of total lifetime costs in the United States and 67 % of total lifetime costs in Brazil. Productivity costs were much
lower using the friction cost approach among those of working age.
Conclusions: Our PVLE model is a novel tool allowing researchers to incorporate the value of lost productivity due
to premature mortality into economic analyses of treatments for diseases or health interventions. We provide PVLE
estimates for a number of emerging and developed countries. Including productivity costs in a health economics
study allows for a more comprehensive analysis, and, as demonstrated by our illustration, can have important
effects on the results and conclusions.Background
In the current climate of rising health care costs, evalua-
tions demonstrating the economic value of new health care
interventions are increasingly becoming a necessity [1-4].
These economic evaluations include assessment of the
“costs” and “benefits” of the health care intervention under
consideration. Costs typically include direct costs such as
medical expenditures as well as indirect costs due to lost
productivity from morbidity or premature mortality [2,3,5].* Correspondence: jmenzin@bhei.com
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reproduction in any medium, provided the orSimilarly, burden of disease studies, which help motivate
interest and investment in new health care interventions,
usually require assessment of both direct and indirect
costs.
There is a general consensus that, when feasible,
researchers should conduct their health economic analyses
from the societal perspective, as it is the most comprehen-
sive [2-7]. Moreover, for an analysis to truly be from the
societal point of view, productivity costs must be taken
into account [2,3,6]. For example, a disease may affect soci-
ety not only through the financial transactions related to
the exchange of goods and services to treat that disease,
but also through the loss of individuals’ contributions toLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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There is disagreement on whether to include productivity
costs when cost-utility analyses are undertaken [3-5,8].
However, as many as one-third of published cost-utility
studies have incorporated indirect costs [2], and other
forms of economic evaluation (e.g., cost-benefit analysis)
call for the inclusion of such costs on a routine basis [5].
In the health economics literature, there are two compet-
ing methodologies for estimating productivity costs: the
human capital approach and the friction cost method
[9-12]. The human capital approach assumes no un-
employment and captures all lost productivity due to
disease mortality by assuming individuals who died pre-
maturely would have worked full time until the end of
their working lives. In contrast, the friction cost method
captures lost productivity costs only until a worker would
likely be replaced by someone currently unemployed plus
the transaction costs associated with identifying the re-
placement worker [13]. The human capital approach can
also be adapted to include unpaid labor, such as household
work, in productivity cost estimates [3] and has been more
widely accepted and recommended [6,14-16].
This paper describes a model that we developed to es-
timate productivity costs due to premature mortality for
a range of developed and emerging countries around the
world. We elected to use the human capital approach,
but we included sensitivity analyses that employed the
friction cost method. Utilizing a variety of inputs, includ-
ing population demographics, the percentage of working
age people employed or seeking employment (i.e., the
labor force participation rate), and life expectancy by age
and gender, we apply a consistent methodology across
countries. To our knowledge, there are no existing mod-
els that provide estimates of productivity costs for such
a wide array of countries or that utilize a methodology
that can be modified to estimate productivity costs of
specific subgroups of interest.
In this paper our aims are: 1) to present a transparent,
generic model based on accepted analytic methods that
allows users to assess the present value of lifetime earnings
(PVLE) for select developed and emerging countries; 2) to
discuss results from this model for a sample of diverse
countries; and 3) to highlight an application of our model
by incorporating mortality rates from the Benefits of
Smoking Cessation on Outcomes Model (BENESCO) in
order to estimate smoking-related lost productivity costs.Methods
We selected 29 countries to be included in the model
based on their geographic diversity, and also to represent
a range of developed and emerging countries. Countries
were required to have a minimum amount of data avail-
able (i.e., at least life expectancy, economic participation,and wages) in order to be incorporated into the model;
no data imputation was performed.
We used the following equations to estimate PVLE for
paid work and household work:















sj = the starting age for gender j
nj = life expectancy for starting age for gender j
li,j = economic activity rate for age i and gender j
Wi,j = annual wages for age i and gender j
wi,j = hourly wage for age i and gender j
hi,j = hours of household work for age i and gender j
r = discount rateTable 1 lists the 29 countries included and the types of
data used for each country’s PVLE estimates.
Estimation of default model inputs
Life expectancy
The 2008 World Health Organization (WHO) Life Tables
were used to obtain life expectancy values for all countries
for ages 18 to 75 [17]. By design, the WHO life tables are
stratified by sex and age, in 5-year increments. The WHO
tables are generated based on a systematic review of all
available evidence from surveys, censuses, sample registra-
tion systems, population laboratories and vital registration
on levels and trends in mortality rates [17]. WHO applies a
standard methodology to the analysis of all member state
data. Because a person’s projected life expectancy depends
on his or her current age, the PVLE model uses the
expected average number of years of life left for a person at
age i and gender j.
Economic activity rate
Labor force participation was derived from the economic-
ally active population, as presented by the International
Labor Organization (ILO) [18]. For most countries, values
from 2008 were used in our model; however, when data
were not available, the next most recent year with
complete data was selected. The labor force data, as
reported by the ILO, were stratified by sex and age, in 5-
year increments from ages 18 to 75. Our model assumed a
labor force participation rate of 0 for all persons aged
76 years and older. The ILO refers to the “economically ac-
tive population” as all persons of either sex who furnish



















Africa Egypt Emerging x x x x 8.20 %
South Africa Emerging x x x x 6.50 % x
The Americas Brazil Emerging x x x x 4.80 %
Canada Advanced x x x x x 3.90 % x
Colombia Emerging x x x x 8.60 %
Mexico Emerging x x x x x 6.20 % x
United States Advanced x x x x x 4.50 % x
Asia China Emerging x x x x 14.30 % x
India Emerging x x x x 11.70 % x
Indonesia Emerging x x x x 7.10 % x
Israel Advanced x x x x 3.00 %
Japan Advanced x x x x 3.90 % x
Turkey Emerging x x x x 7.80 % x
Europe Czech Republic Advanced x x x x 8.90 %
Denmark Advanced x x x x x 4.90 %
Belgium Advanced x x x x 5.00 % x
Finland Advanced x x x x 7.90 % x
France Advanced x x x x x 3.30 % x
Germany Advanced x x x x 4.60 % x
Netherlands Advanced x x x x 4.50 %
Poland Emerging x x x x 8.50 % x
Portugal Advanced x x x x x 2.40 % x
Russia Emerging x x x x 10.00 %
Spain Advanced x x x x x 5.70 % x
Sweden Advanced x x x x 6.40 % x
United Kingdom Advanced x x x x x 4.40 % x
Oceania Australia Advanced x x x x 3.30 % x
New Zealand Advanced x x x x 2.70 % x
Papua New Guinea Emerging x x x x 4.30 %
Sources:
(1) As defined by the United Nations Statistics Division, http://unstats.un.org/unsd/methods/m49/m49regin.htm#ftnb.
(2) As defined by the IMF, http://www.imf.org/external/pubs/ft/weo/2010/01/weodata/weoselagr.aspx#a001.
Notes:
Subject to data availability, the largest countries by population and level of development (advanced/emerging), in addition to further examples from each region,
were included.
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vices during a specified time-reference period [18].
Categorization of groups such as the armed forces, mem-
bers of religious orders, persons seeking their first job, sea-
sonal workers or persons engaged in part-time economic
activities may vary between countries. In certain countries,
all or some of these groups are included among the eco-
nomically active, while in others they are treated as in-
active; by necessity, we followed these country-specific
conventions. The data on economically active populationgenerally exclude students, persons occupied solely in do-
mestic duties in their own households, members of collect-
ive households, inmates of institutions, retired persons,
persons living entirely on their own means, and persons
wholly dependent upon others.
Wages
Wage data were gathered from a number of country-
specific statistics websites. ILO estimates of country-
specific wages were used when data from the
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were available for the overall population of each country,
and several countries also had age- and sex-stratified data
available. A country-specific Consumer Price Index (CPI)
from the October 2009 International Monetary Fund
(IMF) World Economic Outlook Database was used to up-
date all wages to 2009 values. It was assumed that all labor
force participants work full-time, as a common basis from
which adjustments are possible.
Discount rates
The choice of appropriate discount rate in analyses of prod-
uctivity costs is controversial and can be varied in this PVLE
model. Social discount rates derived using a social rate of
time preference methodology [19] were applied in the
present value calculation. Discount rates for developing
countries were considerably higher than those for developed
countries; rates for emerging countries ranged from 4–14 %
and rates for advanced countries ranged from 2–9 %.
Value of household work
Although not a primary focus of our calculations, for
certain countries with available data, the model may also
be modified to include the economic value of household
work for persons not participating in the labor force.
Time use surveys were used to provide national esti-
mates of the number of hours spent on unpaid house-
hold work for each gender, when available [20-25]. The
opportunity cost approach, i.e. estimating what a per-
son’s labor would have been worth had those hours been
spent in the paid labor market, was used to estimate the
value, by gender, of time spent on household work. We
also conducted sensitivity analyses that use the replace-
ment cost, based on the average hourly wage for child
care workers, personal care aides, and maids/house-
keepers in the United States [26] rather than the market
wage, to calculate PVLE for household labor using the
35–64 age group as an illustration.
Standardization of input data
Our model calculations account for each age from 18 to





Figure 1 PVLE flow diagram.across countries in uniform age groups or for each distinct
age. We therefore assigned the best data available across
age groups when needed (e.g., the life expectancy reported
for the age group 20–24 was assigned to ages 20, 21, 22,
23, and 24). The model provides PVLE estimates, by sex
and age, for 3 age groupings: 5-years, 10-years, or 3 broad
categories (18–34, 35–64, and 65+ years), depending on
the preference of the researcher using the model. For the
PVLE calculations, the midpoint of each age range was
used by our model. For the purposes of this paper, we re-
port detailed model inputs and results using three large
age groups for five countries as examples. Results are avail-
able for all countries and all 3 age groupings in an on-line
Additional file 1: Appendix.Application of the model and BENESCO case study
Productivity costs due to premature mortality are a key in-
clusion in any economic evaluation from the societal per-
spective. Using age- and gender- specific mortality rates,
productivity costs from our model can easily be incorpo-
rated (Figure 1). To illustrate the impact of incorporating
productivity costs using our model, we estimate PVLE
based on results from the BENESCO model. BENESCO is
a Markov model that simulates the impact of a single quit
attempt for different treatment options and estimates
smoking-related morbidity, mortality, and direct costs [27].
BENESCO generates results for persons who have
attempted to quit using various methods. For convenience,
we therefore arbitrarily show results for smokers who at-
tempt to quit without assistance (i.e., “cold turkey”), one of
the selected strategies for smoking cessation included in
BENESCO. We present the overall societal costs in two ex-
ample countries (one developed and one emerging) broken
down by direct and productivity costs. Sensitivity analysis
of these results using the friction cost methodology was
also conducted. A three-month friction period was
assumed [9,10,28] and employee replacement costs, as
reported by Wang and colleagues [29] included the costs
of hiring and training a new employee ($8,819 in 2009
USD for the United States; adjusted to 3,659 Brazilian
Reals for Brazil based on relative annual wages and average

























Brazil 69.8 76.8 72.4 % 52.4 % 15,924 15,924 2009 Reals
China 72.1 75.7 79.7 % 67.5 % 29,213 29,213 2009 Yuan
Egypt 68.1 70.9 48.4 % 15.9 % 17,623 13,707 2009 Egyptian Pounds
United Kingdom 77.6 81.7 56.7 % 46.3 % 33,268 19,491 2009 British Poundsc
United States 75.7 80.7 72.3 % 58.9 % 42,224 34,164 2009 US Dollarsc
[a] Life expectancy values used in the PVLE model vary by age person has lived until (in 5 year increments); these are for those <1 year old and are presented for
illustrative purposes.
[b] Labor force participation values used in the PVLE model vary by age (in 5 year increments); these are overall figures for the total population and are presented
for illustrative purposes. Values for Brazil and Egypt are for 2007; Values for China, the United Kingdom and the United States are for 2008.
[c] Wage inputs for the United Kingdom and the United States in the PVLE model vary by age (in 5 year increments); these are overall figures for the total
working populations and presented here for illustrative purposes.
Table 3 Present value of lifetime future earnings
estimates for select countries
Country Currency Age Group PVLE
Male Female
Brazil 2009 Brazilian Reals 18-34 273,400 200,901
35-64 177,531 108,677
65+ 54,495 25,114
China 2009 Chinese Yuan 18-34 215,905 174,858
35-64 174,806 94,237
65+ 31,756 7,223
Egypt 2009 Egyptian Pounds 18-34 211,527 49,328
35-64 150,312 29,638
65+ 27,098 3,460
United Kingdom 2009 British Pounds 18-34 590,013 296,950
35-64 366,281 161,067
65+ 37,707 10,085
United States 2009 US Dollars 18-34 757,640 510,682
35-64 530,425 334,154
65+ 103,090 55,163
Note: Results are shown in 3 broad age categories, but the model allows for
reporting in 5- and 10-year age groups as well. Estimates do not include
household productivity costs.
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Findings are presented for a sample of five countries
drawn from developed and emerging countries, includ-
ing Brazil, China, Egypt, the United Kingdom, and the
United States. Selected model inputs for the five sample
countries are presented in Table 2. For illustrative pur-
poses, only sex-stratifications are shown. Not surpris-
ingly, life expectancy is longer in developed countries,
like the United Kingdom and in the United States, and is
longer for women than for men; paid labor force partici-
pation is also consistently higher for men than it is for
women. Annual paid wages are higher for developed
than for emerging countries and, when stratification by
sex was possible, are higher for men than for women.
Table 3 presents PVLE estimates (excluding household
labor costs) stratified by age (using three age groups)
and sex for the five selected developed and emerging
countries. PVLE estimates were highest for younger
people partly because younger people had the most time
ahead of them in the labor force and thus the most po-
tential future productivity. PVLE estimates were higher
for men than for women for primarily two reasons: (1) a
higher percentage of men than women were typically in
the work force; and (2) men typically were paid a higher
wage than women. When the value of lost household
labor is included in the model, using the United States
as an example, PVLE estimates for the 35–64 year-old
age group increase by approximately $120,000 for males
and $194,000 for females. If the replacement cost of
household labor method was used in our model instead
of the opportunity cost approach, the PVLE estimates
would have increased by $55,000 for males and $118,000
for females.
Our model’s PVLE estimates were incorporated into the
BENESCO model for two of these countries – the United
States and Brazil – to estimate the total lifetime costs
among smokers. The inclusion of productivity cost (ex-
cluding household labor) estimates from our model
showed that productivity loss was a substantial share of thetotal cost burden of premature mortality due to smoking,
with direct medical costs accounting for only 25 % of total
lifetime costs in the United States and 33 % of total lifetime
costs in Brazil. Figures 2 and 3 compare productivity cost
results per 1,000 smokers undergoing a quit attempt for
these two countries using human capital-based results
from our model and using the friction cost method. These
figures indicate that estimates using the human capital ap-
proach were substantially higher than those using the fric-
tion cost approach for the 18–34 and 35–64 age groups
(23 and 15 times higher for the United States, and 21 and
15 times higher for Brazil, respectively). However, human
































Figure 2 Lifetime productivity costs per 1000 smokers with a quit attempt by age, United States, human capital approach vs. friction
cost approach.
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for both countries.
Discussion
In this paper, we present country-specific productivity
cost estimates for several countries. Our human capital-
based PVLE estimates for the US were slightly lower
than those calculated by Grosse et al [15]. Their esti-
mated PVLE (excluding household work) for males ran-
ged from just under $16,000 to over $1,000,000 (2007
























Figure 3 Lifetime productivity costs per 1000 smokers with a quit att
cost approach.approximately $22,000 to $829,000 across similar age
groups (age groupings not reported in this paper). This
is likely due to our differing methodologies in estimating
annual wages. Grosse et al. aggregated hourly wage esti-
mates to an annual level based on estimated hours
worked per week, whereas, to ensure a certain level of
consistency across countries methodologically, we used
average annual wages by age and sex. Estimates from
our model for China were on par with the literature for
the human capital-based method as well. For males be-







empt by age, Brazil, human capital approach vs. friction
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and 209,000 (2009 Chinese Yuan), while Sung et al. esti-
mated a range of 27,350 and 264,000 (2003 Chinese
Yuan) [30].
The most notable critique of the human capital approach
is that it measures potential lost production instead of ac-
tual lost production, which could lead to significant over-
estimation of productivity costs due to premature
mortality [9-11]. It has been argued that the friction cost
methodology is more precise than the human capital
methodology in that it captures actual productivity losses
versus the total potential loss in the human capital ap-
proach [9,10]. However, the level of detail and extensive
data required for this method (e.g., industry- or education-
level data on average length of vacancy for an open pos-
ition, disease-related average frequency and length of ab-
sence from work) made its application to our objective of
estimating productivity costs across several countries un-
realistic. We did include a sensitivity analysis using a rough
approximation of the friction cost approach for the US and
Brazil and found, as might be expected, substantially lower
costs for lost productivity among those of working age.
Further research into available sources of data to fully im-
plement the friction cost approach would be valuable, such
as length of the friction period for various occupations,
availability of surplus labor, and whether positions are filled
by unemployed workers or employed workers who are
changing jobs (and thus generating a new friction period).
By its nature, our model is subject to certain limitations,
namely surrounding data availability. It was not possible to
stratify wages by age and sex in all countries, or to assess
variation by occupation. Employment statistics did not dis-
tinguish between full-time and part-time work in most
countries; our use of a full-time work assumption may
overstate lost productivity costs. However, proportionate
downward adjustments are possible to allow for data or
assumptions about part-time work. Labor force participa-
tion rates and wages both vary based on general economic
conditions, which would influence our estimates (e.g.,
higher estimates in good economic times, lower estimates
in bad times). Due to this data variability, along with differ-
ences in epidemiology among diseases of interest and dif-
ferences across health care systems, we recommend, in
general, that researchers use the PVLE estimates to con-
duct single country analyses. Despite these known limita-
tions, there has been recent interest in analysis of the
transferability of economic evaluations across countries
[31,32]. Thus, it may be possible to cautiously relate results
between countries if special attention is given to assessing
the comparability of model inputs and any key differences
in country characteristics.
Our model evaluated lost productivity based on averages
for general populations, including persons in the paid work
force and those who are not, rather than only for thosewith specific diseases or comorbidities. Although these
may limit the direct relevance of our model inputs and cal-
culation to specific diseases, it strengthens the
generalizability of our findings regarding the societal prod-
uctivity costs. We also focused only on the value of lost
productivity due to premature mortality. We recognize
that indirect costs also should include morbidity costs,
which were beyond the scope of our analysis. Finally, it
could be argued that the actual cost to society from prema-
ture mortality would be production loss minus consump-
tion loss, which would overstate productivity losses under
the human capital approach.
We expanded on the traditional human capital model by
making it possible to incorporate estimates of the value of
household work, which has known limitations, including,
for example, the transfer of gender wage differentials in the
paid labor market to the production of household services
[33]. Furthermore, we acknowledge that our use of an op-
portunity cost approach to estimate the value of household
work rather than a replacement cost (i.e., the cost to hire
someone to complete the household work) results in
higher estimates of PVLE when household work is
included, as exhibited by the sensitivity analysis that we
conducted. As stated previously, due to data limitations we
chose to use the opportunity cost approach in this model.
As with any valuation based on age- and gender- specific
wages, these PVLE estimates are biased against older and
female populations. Despite the potential ethical considera-
tions surrounding valuing one life more than another, it is
still recommended to use age- and gender-specific wages
where possible, as they are more targeted and accurate [5].
Also, in order to collect some input values from source
documents written in other languages, we used Google
Translate, which produced English versions that were im-
perfect and sometimes required additional interpretation.
Our analysis highlights the need for uniform data
across countries. International organizations, such as the
WHO and ILO, provide useful country-specific esti-
mates for important model inputs such as life expect-
ancy and labor force participation. However, where there
are gaps in standardized data, country-specific data
sources had to be used, which introduced some meth-
odological variability into our results. Finally, the use of
broader age categories leads to more imprecision in esti-
mates of PVLE, so we recommend that researchers use
the 5-year age brackets when feasible.
Conclusions
Our results indicate important differences in human
capital-based productivity costs by age and sex, and, as
seen in our smoking case study, including productivity
cost in a health economic evaluation can have a signifi-
cant effect on the overall conclusions of level of burden.
The inclusion of productivity cost estimates from our
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showed that productivity loss due to premature mortal-
ity was a substantial share of the total cost burden of
smoking in both the United States and Brazil, account-
ing for over 75 % and 67 % in each country, respectively.
Contributing to the existing productivity cost litera-
ture, our methods for estimating PVLE can be used
across a wide range of emerging and developed coun-
tries using the well-accepted human capital approach.
Currently, researchers can access productivity cost esti-
mates for 29 countries available in an on-line Appendix
(http://www.biomedcentral.com/bmcmedresmethodol/).
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